Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I chemoprotontherapy for stage IB–III esophageal carcinoma
jRCTs032180029Phase 1Completed
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cisplatin and fluorouracil in Esophageal Squamous Cell Carcinoma (ESCC) and esophageal adenosquamous carcinoma (ASC). Primary endpoint: Proportion of dose-limiting toxicity. Started Feb 2015; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)esophageal adenosquamous carcinoma (ASC)
Beyond the preview
Go deeper on jRCTs032180029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs032180029.